Granules India Limited and NIPER Join Forces to Establish Dr. Chigurupati Center of Excellence for Sustainable Pharmaceutical Innovation

Hyderabad: Granules India, a prominent vertically integrated pharmaceutical company, has forged a groundbreaking partnership with the prestigious National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Chandigarh. The collaboration was formalized through the signing of a Memorandum of Understanding (MOU) to create the Dr. Chigurupati Center of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).

This pioneering initiative is set to revolutionize pharmaceutical research and development by placing sustainability and innovation at its core. The center will focus on critical areas, including the exploration of plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods for producing directly compressible crystals, the promotion of solvent-free pharmaceutical processes, and the development of resource-efficient and energy-efficient pharmaceutical products.

The partnership will foster collaborative research initiatives, ensuring a seamless exchange of knowledge between the pharmaceutical industry and academia. Granules India Limited has committed to support the establishment and ongoing operation of the research center, which will feature state-of-the-art laboratories and research facilities within the NIPER campus. This strategic alliance represents a significant step toward emphasizing sustainability within the pharmaceutical sector, promising transformative changes for the industry and society on a global scale.

Commenting on the collaboration, Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India Limited, remarked, "This partnership represents more than just cooperation; it embodies a shared vision. At Granules India, we are committed to pushing the boundaries of pharmaceutical innovation, and through this partnership with NIPER, our goal is not only to develop life-saving medicines but to make a meaningful difference. The CCE-ISPD stands as a testament to our dedication to sustainable pharmaceutical development, and we are excited about the transformative impact it will have on the industry and society."

Professor Dulal Panda, Director of NIPER, expressed his enthusiasm, saying, "NIPER has always been a frontrunner in pharmaceutical research and education. Collaborating with Granules India opens new horizons for our students and researchers to engage in real-world, impactful projects. The CCE-ISPD will serve as a nurturing ground for innovative ideas and sustainable solutions, shaping the future of pharmaceuticals. We are honored to work alongside Granules India, a pioneering force in the industry, and together, we will redefine the landscape of sustainable pharmaceutical research and development."